VOLUNTARY ANNOUNCEMENT-APPROVAL OF NDA BY THE MFDS FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND DIFFUSE LARGE B-CELL LYMPHOMA

Jul 30, 2021View PDF